ClinicalTrials.Veeva

Menu

Pediatric Rhabdomyolysis in the Pediatric Intensive Care Unit: A Retrospective Cohort Study

H

Hannover Medical School (MHH)

Status

Completed

Conditions

Rhabdomyolysis

Study type

Observational

Funder types

Other

Identifiers

NCT07851987
RHABDO-2026-01

Details and patient eligibility

About

This retrospective observational cohort study aims to evaluate the clinical characteristics, causes, intensive care management, and outcomes of pediatric patients with rhabdomyolysis admitted to the Pediatric Intensive Care Unit (PICU) at Hannover Medical School between 2007 and 2020. The study uses routinely collected clinical data from medical records without any study-related intervention or additional patient contact.

The primary objective is to identify factors associated with acute kidney injury, mortality, organ failure, and intensive care resource utilization. In addition, the study aims to develop a prognostic score to support early risk stratification of critically ill children with rhabdomyolysis. The findings may improve the understanding of this rare condition and support future clinical decision-making.

Full description

Rhabdomyolysis is a rare but potentially life-threatening condition in children characterized by skeletal muscle injury and the release of intracellular components into the circulation. Clinical presentation ranges from mild disease to severe complications, including acute kidney injury, multiple organ dysfunction, and death. Current evidence is limited because most published studies are based on small retrospective case series, and prognostic factors for critically ill pediatric patients remain insufficiently characterized.

This is a single-center, retrospective observational cohort study conducted at the Department of Pediatric Cardiology and Intensive Care Medicine, Hannover Medical School, Germany. The study includes pediatric patients treated in the Pediatric Intensive Care Unit (PICU) between January 1, 2007, and December 31, 2020, with a diagnosis of rhabdomyolysis. Clinical, laboratory, and treatment data are extracted from routinely collected electronic medical records. No study-related interventions are performed, and no additional patient contact takes place.

The study aims to characterize the etiology, clinical course, intensive care resource utilization, and outcomes of pediatric rhabdomyolysis in routine clinical practice. Furthermore, routinely collected clinical and laboratory parameters will be evaluated to develop a prognostic model for early risk stratification of acute kidney injury and mortality in critically ill children. The results are expected to improve the understanding of this rare disease and provide evidence to support future clinical management and research.

Enrollment

55 patients

Sex

All

Ages

Under 20 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pediatric patients admitted to the Pediatric Intensive Care Unit (PICU) at Hannover Medical School, Germany, between January 1, 2007, and December 31, 2020.
  • ICD-10 diagnosis codes: M62.2 (non-traumatic muscle necrosis) or T79 (traumatic rhabdomyolysis)
  • Peak serum creatine kinase (CK) concentration ≥1,000 IU/L.
  • Availability of complete clinical data required for retrospective analysis.

Exclusion criteria

  • Peak serum creatine kinase (CK) concentration < 1,000 IU/L.
  • Incomplete clinical data preventing retrospective analysis.

Trial design

55 participants in 1 patient group

Pediatric patients with rhabdomyolysis
Description:
Pediatric patients with rhabdomyolysis admitted to the Pediatric Intensive Care Unit (PICU) at Hannover Medical School between January 1, 2007, and December 31, 2020, who fulfilled the predefined eligibility criteria and were included in the final retrospective analysis. Clinical data were obtained from routinely collected medical records.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems